Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

KREMOINT PHARMA PRIVATE LIMITED

Active

KREMOINT PHARMA PRIVATE LIMITED having CIN U24230MH1992PTC066737 is 33 years & 29 days old Private Indian Company incorporated on 12 May 1992. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 2,500,000 and its paid up capital is Rs. 600,000. It's NIC code is 24230 (which is part of its CIN).

As per the NIC code, it is involved in . KREMOINT PHARMA Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 07-20-2024. Directors of KREMOINT PHARMA are Vibha Gagan Sharma and Yesha Bhadresh Thakkar.

KREMOINT PHARMA ' Corporate Identification Number (CIN) is U24230MH1992PTC066737 and its registration number is 066737. Users may contact KREMOINT PHARMA on its Email address - info@kremointpharma.com Registered address of KREMOINT PHARMA is B-8, ADDITIONAL AMBERNATH MIDC OPP. ANAND NAGAR OCTROI NAKA,,AMBERNATH,Maharashtra,India-421506. Current status of KREMOINT PHARMA PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
2,500,000

as on 10/06/2025

Paid Up Capital
600,000

as on 10/06/2025

Company Age
33 Year, 0 Months
Last Filing with ROC
0 Year, 10 Months

Company Information

CIN U24230MH1992PTC066737
Company Status Active
Registration Number 066737
Date of Incorporation 05/12/1992
RoC ROC Mumbai
Company Age 33 years & 37 days
Authorized Capital ₹ 2500000
Paid-up capital ₹ 600000
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID info@kremointpharma.com
Address B-8, ADDITIONAL AMBERNATH MIDC OPP. ANAND NAGAR OCTROI NAKA, AMBERNATH AMBERNATH Maharashtra India 421506
Website kremointpharma.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
GAGAN HARSH SHARMA
01/27/2022 07939421 *****5163R 3 years
Director
BHADRESH KESHAVJI THAKKAR
09/01/2018 00774787 *****9201G 6 years
Director
VIBHA GAGAN SHARMA
04/04/2023 02307289 *****5844H 2 years
Director
SHRUTI VISHAL RAO
08/16/2024 00731501 *****5843A 0 years
Director
YESHA BHADRESH THAKKAR
08/16/2024 10670379 *****0989R 0 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
BLISS GVS PHARMA LIMITED
Active
10,49,65,572.00 1 Maharashtra
ECO RICH COSMETIC INDIA PRIVATE LIMITED
Active
1,16,50,000.00 1 Maharashtra

Charges on assets

1

Others

No. of Loans: 8

Total Amount: 284,600,000.00 cr

2

HDFC BANK LIMITED

No. of Loans: 1

Total Amount: 3,395,000.00 cr

3

The Bharat Co-operative Bank(Mumbai) LTD

No. of Loans: 4

Total Amount: 94,000,000.00 cr

4

The Bharat Co-operative Bank (Mumbai) Limited

No. of Loans: 1

Total Amount: 4,200,000.00 cr

5

The Bharat cooperative Bank (Mumbai) Ltd

No. of Loans: 1

Total Amount: 6,800,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Others Manpada Road, Dombivali (East), 50,000,000 02 Feb, 2024 - - Open
Others Manpada Road, Dombivali (East), 100,000 11 Jul, 2023 - - Open
Others Bandra Kurla Complex, 10,000,000 27 May, 2023 - - Open
HDFC BANK LIMITED Lower Parel (West), 3,395,000 25 Feb, 2020 - 08 May, 2023 Closed
Others Premises CHSL, Hirachand Desai Road,Ghatkopar(W) 10,000,000 07 Aug, 2018 - 24 Aug, 2020 Closed
Others Premises CHSL, Hirachand Desai Road,Ghatkopar(W) 10,000,000 17 Jul, 2018 - 24 Aug, 2020 Closed
Others Dombivli (East), 4,500,000 10 Feb, 2017 24 Apr, 2017 06 Jun, 2017 Closed
The Bharat Co-operative Bank(Mumbai) LTD 1ST FL,JUNCTION OF J.V.RD AND HIRACHAND DESAI ROAD 25,000,000 03 Jan, 1994 29 Jan, 2011 19 Jul, 2013 Closed
Others Dombivli (East), 125,000,000 25 Mar, 2013 10 Feb, 2017 14 Mar, 2018 Closed
Others Manpada Road, Dombivali (East), 75,000,000 26 Apr, 2013 19 Nov, 2020 23 Dec, 2022 Closed
The Bharat Co-operative Bank(Mumbai) LTD 1ST FL,JUNCTION OF J.V.RD AND HIRACHAND DESAI ROAD 15,000,000 31 Mar, 1998 16 Jun, 2008 19 Jul, 2013 Closed
The Bharat Co-operative Bank (Mumbai) Limited Ghatkoper (West) 4,200,000 10 Apr, 2003 - 13 Jul, 2011 Closed
The Bharat cooperative Bank (Mumbai) Ltd 1st Floor, junction of J.V. Road Ghatkopar (West) 6,800,000 04 Mar, 2002 - 13 Jul, 2011 Closed
The Bharat Co-operative Bank(Mumbai) LTD 1ST FL,JUNCTION OF J.V.RD AND HIRACHAND DESAI ROAD 44,000,000 11 Oct, 2011 - 19 Jul, 2013 Closed
The Bharat Co-operative Bank(Mumbai) LTD Flr, Junction of J.V Rd. & H.D Rd, Ghatkopar (W) 10,000,000 29 Jan, 2011 - 19 Jul, 2013 Closed

Registered Details

CIN
U24230MH1992PTC066737
PAN
U24230MH1992PTC066737
Incorporation
0 years , 9 month
Company Email
info@kremointpharma.com
Paid up Capital
₹ 600,000
Authorised Capital
₹ 2,500,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Kremoint Pharma Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Kremoint Pharma Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Kremoint Pharma Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Kremoint Pharma Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Kremoint Pharma Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Kremoint Pharma Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Kremoint Pharma Private Limited

What is KREMOINT PHARMA PRIVATE LIMITED ?

KREMOINT PHARMA PRIVATE LIMITED having CIN U24230MH1992PTC066737 is 0 years , 9 month old Private Indian Company incorporated with MCA on 16 Aug 2024. KREMOINT PHARMA PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 2,500,000 and paid-up capital is 600,000.

What is the CIN of KREMOINT PHARMA PRIVATE LIMITED?

CIN of KREMOINT PHARMA PRIVATE LIMITED is U24230MH1992PTC066737.

Where is KREMOINT PHARMA PRIVATE LIMITED located?

Address of KREMOINT PHARMA PRIVATE LIMITED is B-8, additional ambernath midc opp. anand nagar octroi naka,,ambernath,maharashtra,india-421506,.

Who are the directors of KREMOINT PHARMA PRIVATE LIMITED ?

The company has 7 directors/key management personnel . .,gagan Sharma,bhadresh Thakkar,vibha Sharma,vibha Sharma,shruti Rao,yesha Thakkar,

What is the contact details of KREMOINT PHARMA PRIVATE LIMITED ?

Email : info@kremointpharma.com
Address : B-8, ADDITIONAL AMBERNATH MIDC OPP. ANAND NAGAR OCTROI NAKA, AMBERNATH AMBERNATH Maharashtra India 421506

What does KREMOINT PHARMA PRIVATE LIMITED do?

KREMOINT PHARMA PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry